Moneycontrol
HomeNewsIndiaCOVID-19 vaccine | Serum Institute's Cyrus Poonawalla says booster dose of Covishield is needed
Trending Topics

COVID-19 vaccine | Serum Institute's Cyrus Poonawalla says booster dose of Covishield is needed

Serum Institute of India (SII) Chairman Cyrus Ponawalla said he and several employees have taken a third dose of Covishield

August 18, 2021 / 14:29 IST
Story continues below Advertisement

Cyrus Poonawalla said the ideal gap between two doses of Covishield is two months, as against the 12-16 weeks gap mandated by the government.

Serum Institute of India (SII) Chairman Cyrus Poonawalla said a third or booster dose of Covishield is needed six months after the second dose of the vaccine.

On August 13, Ponawalla said he and several SII employees have taken a third dose of Covishield, AstraZeneca's vaccine against COVID-19, according to a PTI report.

Story continues below Advertisement

"After six months, the antibodies go down and that is why I have taken the third dose. We have given the third dose to our seven to eight thousand SII employees. For those who have completed the second dose, it is my request to take a booster dose (third dose) after six months," Poonawalla said, as quoted by the news agency.

The SII Chairman said the ideal gap between two doses of Covishield is two months, as against the 12-16 week gap mandated by the government.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show